Talphera (NASDAQ:TLPH) Stock Price Down 1.5% – What’s Next?

Talphera, Inc. (NASDAQ:TLPH)’s share price traded down 1.5% during mid-day trading on Friday . The stock traded as low as $1.3140 and last traded at $1.35. 89,522 shares changed hands during trading, a decline of 80% from the average session volume of 441,854 shares. The stock had previously closed at $1.37.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of Talphera in a report on Friday, July 17th. HC Wainwright began coverage on shares of Talphera in a report on Friday, June 5th. They set a “buy” rating and a $3.00 price objective for the company. Westpark Capital started coverage on shares of Talphera in a research report on Thursday, April 30th. They issued a “buy” rating and a $3.00 target price for the company. Finally, Zacks Research upgraded shares of Talphera to a “hold” rating in a research report on Monday, June 8th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Talphera presently has a consensus rating of “Hold” and an average target price of $3.00.

Talphera Stock Performance

The stock has a 50-day moving average of $1.03 and a two-hundred day moving average of $0.93. The company has a market cap of $70.06 million, a P/E ratio of -4.35 and a beta of 0.70.

Talphera (NASDAQ:TLPH) last issued its earnings results on Wednesday, May 13th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.03. As a group, sell-side analysts forecast that Talphera, Inc. will post -0.26 EPS for the current fiscal year.

Institutional Investors Weigh In On Talphera

Institutional investors have recently made changes to their positions in the business. Group One Trading LLC raised its position in Talphera by 3,224.0% in the 3rd quarter. Group One Trading LLC now owns 30,415 shares of the company’s stock worth $27,000 after purchasing an additional 29,500 shares during the period. Virtu Financial LLC purchased a new stake in Talphera during the third quarter valued at about $29,000. Persistent Asset Partners Ltd purchased a new stake in Talphera during the fourth quarter valued at about $42,000. Mariner LLC grew its stake in shares of Talphera by 132.0% during the fourth quarter. Mariner LLC now owns 58,000 shares of the company’s stock valued at $66,000 after buying an additional 33,000 shares during the last quarter. Finally, Dauntless Investment Group LLC bought a new position in shares of Talphera during the third quarter valued at about $89,000. Hedge funds and other institutional investors own 37.67% of the company’s stock.

Talphera Company Profile

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.